| - GRCh37:
- Chr5:149460567-149460568
- GRCh38:
- Chr5:150081004-150081005
| CSF1R | E24fs | Brain abnormalities, neurodegeneration, and dysosteosclerosis | Likely pathogenic (Feb 21, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149457800
- GRCh38:
- Chr5:150078237
| CSF1R | P202S, P54S | Brain abnormalities, neurodegeneration, and dysosteosclerosis | Uncertain significance (May 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149456988
- GRCh38:
- Chr5:150077425
| CSF1R | P247L, P99L | Brain abnormalities, neurodegeneration, and dysosteosclerosis | Uncertain significance (Oct 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149440456
- GRCh38:
- Chr5:150060893
| CSF1R | | not provided, Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1
| Benign/Likely benign (Apr 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149457748
- GRCh38:
- Chr5:150078185
| CSF1R, LOC111188154 | A219D, A71D | Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1, not provided
| Uncertain significance (Nov 4, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149439322
- GRCh38:
- Chr5:150059759
| CSF1R | Q543H, Q691H | not provided, Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1
| Conflicting interpretations of pathogenicity (Oct 16, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:149459797
- GRCh38:
- Chr5:150080234
| CSF1R | G137V | Brain abnormalities, neurodegeneration, and dysosteosclerosis, Hereditary diffuse leukoencephalopathy with spheroids | Uncertain significance (Feb 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149449420
- GRCh38:
- Chr5:150069857
| CSF1R | | Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1, not provided
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149435759
- GRCh38:
- Chr5:150056196
| CSF1R | | not provided, Brain abnormalities, neurodegeneration, and dysosteosclerosis, Hereditary diffuse leukoencephalopathy with spheroids
| Benign (Jul 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149437190
- GRCh38:
- Chr5:150057627
| CSF1R | | Hereditary diffuse leukoencephalopathy with spheroids, Brain abnormalities, neurodegeneration, and dysosteosclerosis, not provided
| Benign (Jul 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149447784
- GRCh38:
- Chr5:150068221
| CSF1R | Y392*, Y540* | Brain abnormalities, neurodegeneration, and dysosteosclerosis | Pathogenic (May 5, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149441390
- GRCh38:
- Chr5:150061827
| CSF1R | W402*, W550* | Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1 | Uncertain significance (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149435626
- GRCh38:
- Chr5:150056063
| CSF1R | W691C, W839C | Brain abnormalities, neurodegeneration, and dysosteosclerosis | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149459858
- GRCh38:
- Chr5:150080295
| CSF1R | V117M | Brain abnormalities, neurodegeneration, and dysosteosclerosis | Uncertain significance (Nov 4, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149449544
- GRCh38:
- Chr5:150069981
| CSF1R | V320L, V468L | not provided, Brain abnormalities, neurodegeneration, and dysosteosclerosis | Uncertain significance (Jun 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149440465
- GRCh38:
- Chr5:150060902
| CSF1R | H643Q, H495Q | not provided | Uncertain significance (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149441159
- GRCh38:
- Chr5:150061596
| CSF1R | | Brain abnormalities, neurodegeneration, and dysosteosclerosis | Pathogenic (Jun 21, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr5:149440309-149440310
- GRCh38:
- Chr5:150060746-150060747
| CSF1R | | Brain abnormalities, neurodegeneration, and dysosteosclerosis | Pathogenic (Jun 21, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr5:149440654
- GRCh38:
- Chr5:150061091
| CSF1R | | not specified | Uncertain significance (Nov 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149459812
- GRCh38:
- Chr5:150080249
| CSF1R | P132L | Brain abnormalities, neurodegeneration, and dysosteosclerosis | Pathogenic (Jun 21, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr5:149449505
- GRCh38:
- Chr5:150069942
| CSF1R | Q481*, Q333* | Hereditary diffuse leukoencephalopathy with spheroids, not provided, Inborn genetic diseases
| Pathogenic (Aug 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149440513-149440515
- GRCh38:
- Chr5:150060950-150060952
| CSF1R | K627del, K479del | not provided | Uncertain significance (Sep 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr5:149460553
- GRCh38:
- Chr5:150080990
| CSF1R | | Brain abnormalities, neurodegeneration, and dysosteosclerosis, Hereditary diffuse leukoencephalopathy with spheroids, not provided
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149460445
- GRCh38:
- Chr5:150080882
| CSF1R | | Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1, not provided, Hereditary diffuse leukoencephalopathy with spheroids | Benign (Oct 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149457678
- GRCh38:
- Chr5:150078115
| CSF1R, LOC111188154 | | Brain abnormalities, neurodegeneration, and dysosteosclerosis, not provided, Hereditary diffuse leukoencephalopathy with spheroids
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149440465
- GRCh38:
- Chr5:150060902
| CSF1R | | not provided, Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1, Hereditary diffuse leukoencephalopathy with spheroids | Benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149433597
- GRCh38:
- Chr5:150054034
| CSF1R | | Hereditary diffuse leukoencephalopathy with spheroids, Brain abnormalities, neurodegeneration, and dysosteosclerosis, not provided
| Benign (Jul 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149433596
- GRCh38:
- Chr5:150054033
| CSF1R | | Brain abnormalities, neurodegeneration, and dysosteosclerosis, not provided, Hereditary diffuse leukoencephalopathy with spheroids
| Benign (Jul 30, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:149435879
- GRCh38:
- Chr5:150056316
| CSF1R | R782H, R634H | Brain abnormalities, neurodegeneration, and dysosteosclerosis, Leukoencephalopathy, diffuse hereditary, with spheroids 1, not provided, Hereditary diffuse leukoencephalopathy with spheroids | Pathogenic/Likely pathogenic (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |